Crye-Leike Inc. argues it is entitled to protection under NAR's settlement due to 2022 sales volume below $2 billion. The company claims that only it, and not its six subsidiaries, is named in a lawsuit, asserting these subsidiaries operate independently with separate management and accounting. The court documents state that proving Crye-Leike's control over these subsidiaries is crucial for the plaintiffs to exclude it from the settlement, as they need to illustrate the companies acted as a single entity rather than independently.
Crye-Leike believes it should be covered by NAR's settlement due to its 2022 sales volume not exceeding $2 billion, and argues independence among its subsidiaries.
The plaintiffs must demonstrate that Crye-Leike and its independent subsidiaries acted collectively as a single entity to exclude them from the NAR settlement.
Collection
[
|
...
]